Pharmiweb.com RSS Feeds 
PharmiWeb Candidate Blog
Features
23 Feb 09
Health economics is a growing sub-discipline of economics and studies the allocation of scarce resources in health care.
Editor
20 Feb 09
More than a billion people worldwide are affected by the consequences of high blood pressure and many more suffer without diagnosis, due to a lack of ubiquitous symptoms...
Max Golby
09 Feb 09
One of the greatest compliments I have ever heard paid in this industry is “By the time she’s finished with the SOPs, you might even want to read them.†But what a sad indication this is of the general opinion of the documents on which we depend.
Jo Hills - Field Reporter
09 Feb 09
There are constant references in the regulations to the Quality Management System, or QMS, expected to be in place at every GxP-compliant site. The QMS is generally described in the Quality Manual and reflected in approved, controlled Standard Operating Procedures (SOPs).
Jo Hills - Field Reporter
05 Feb 09
Start looking for a new role as soon as you know your role is at an end and the prospects internally for reassignment are limited. Even if you will get a redundancy package, it is easier to be re-employed if you have the shortest possible break.
Ann Maloney BSc FICR, Managing Consultant
29 Jan 09
Recent talks are about the recession, economic downturn, credit crunch and so on. However, the pharma giant Pfizer made a remarkable start in 2009.
A. Shabeer Hussain
.jpg)
28 Jan 09
The speculation that started last year and then reappeared last week surrounding a possible major acquisition by Pfizer has come to a close.
CBR Pharma Insights
26 Jan 09
According to eHealth Forum’s latest survey more than half the respondents were NOT intending to get vaccinated against the flu virus this year… And for those that do, it might still be too late…
eHealth Forum
23 Jan 09
Ten years from now the pharmaceutical industry is going to be a very different industry than it is today; and looking back from that point we will see that the foundation for many of the changes to the pharmaceutical business model were laid in 2009. In Part One of a four part commentary on the outlook for 2009, we focus on the choice between portfolio diversification versus new product development.
CBR Pharma Insights
23 Jan 09
Ten years from now the pharmaceutical industry is going to be a very different industry than it is today; and looking back from that point we will see that the foundation for many of the changes to the pharmaceutical business model were laid in 2009. In Part One of a four part commentary on the outlook for 2009, we focus on the choice between portfolio diversification versus new product development.
CBR Pharma Insights
22 Jan 09
The World Dermatological Market Outlook, 2009-2023
Visiongain
20 Jan 09
Pharma bigwigs confirm to speak in India’s biggest event in pharma:
More than 40 Industry leaders will chart the course ahead for the Indian Pharmaceutical and allied Industries
Media release from K2 communications Pvt Ltd
19 Jan 09
With more than 20,000 students, Kingston University is the largest provider of higher education in South West London, offering an extensive range of undergraduate and postgraduate programmes both in the United Kingdom and overseas. The University is renowned for teaching excellence, has established itself as a growing force in research and is widely respected as a pioneer in e-learning.
Alison Barbuti
07 Jan 09
PharmiWeb is pleased to collaborate with Touch Briefings to provide clinical research professionals FREE access to their latest report - Clinical Trial Management: Enabling Operational Efficiency.
Liam ONeill
06 Jan 09
The Nanotechnology Knowledge Transfer Network (NanoKTN), one of the UK’s primary knowledge-based networks for Micro and Nanotechnologies, has announced its support for one of the largest funding rounds that has been made available to the micro and nanotechnology sector.
Graham Thatcher
24 Dec 08
This feature has been provided by Jonathan Hart-Smith, Managing Director of CK Clinical Limited.
The feature contains useful information for rapport buliding.
Jonathan Hart-Smith - CK Clinical Limited
24 Dec 08
This feature has been provided by Jonathan Hart-Smith,
Managing Director of CK Clinical Limited.
The feature contains useful information for Hiring Managers.
Jonathan Hart-Smith - CK Clinical Limited
16 Dec 08
Naseem Javed, widely recognized as global authority on global corporate nomenclature, image and cyber-branding, author of Naming for Power. Naseem is on global name identity projects and lecturing at various conferences on these ICANN issues.
Naseem Javed
15 Dec 08
- Dossier admits UK biotech at breaking point.
- Sector can still flourish – but needs major investment.
- Industry calls for new investment partnership with government.
- Creation of two new investment super funds critical to future success.
Ramsay Smith - Media House
03 Dec 08
Paul Hartigan reports from the Financial Times Pharmaceutical Conference: London December 2nd and 3rd 2008
Paul Hartigan
02 Dec 08
Awards for Innovation, Export Achievement and NHS Partnership held at ERBI's Winter Ball at The Imperial War Museum, Duxford on November 29th 2008.
Aviva Grisby - Holdsworth Associates
28 Nov 08
‘More universities should provide courses that offer hands-on experience to better prepare their students.’ This is the response from the Head of Cranfield Health, Professor Joe Lunec, after a report claimed that those leaving universities lacked the required knowledge and skills to progress in the UK’s pharmaceutical industry.
Naomie Stanford-Jones
26 Nov 08
Our eMarketing team at PharmiWeb Solutions often works with pharma brand teams to find new ways to reach healthcare professionals with news of the latest product or initiative. And sometimes, it can be challenging, with all of the pressures and time constraints that the average primary care practice faces.
Editor
24 Nov 08
We are facing a world where microbes once again have the potential to cause untreatable diseases, due to the resistance to virtually all available drugs. WHO suggests that even if the pharmaceutical industry were to step up the efforts to develop new drugs immediately, some diseases might still not have any effective therapies within the next ten years.
Visiongain
19 Nov 08
It takes courage to invest €300 million in a production site during a time of financial turmoilâ€,pointed out Karl-Ludwig Kley, Executive Board Chairman of the pharmaceutical company Merck Serono, this week.
Olwen Glynn Owen
17 Nov 08
The global pain market generated total sales of $34bn in 2007 – but what will the figures be in the next 5 and 10 years? This report tells you.
The pain market has marked strengths and advantages, but is also limited by problems and concerns.
Suvitha Damodaran - Visiongain - Ltd
14 Nov 08
White paper from CERAM highlights novel techniques to expose fake medicines and unlicensed manufacturing processes
Mandy Rymill - CERAM
14 Nov 08
The UK’s success as a global centre of biomedical excellence is under threat in the long-term. A new report by the Association of the British Pharmaceutical Industry (ABPI) has highlighted serious concerns about the supply of skills that support the research and development of new medicines.
Editor
14 Nov 08
The global addiction market is significantly undervalued. The world’s population has a large unmet need for addiction therapy drugs. Are you ready for the opportunities this presents?
Suvitha Damodaran - Visiongain Ltd
10 Nov 08
The gastrointestinal (GI) disorders market has been one of the largest and most profitable therapeutic areas in the world pharmaceutical industry. With a reported $49.9bn in revenues in 2007, the GI disorders market competes consistently with cardiovascular diseases and oncology for the top 3 therapeutic areas in terms of market value.
Suvitha Damodaran - Visiongain
